Literature DB >> 16246936

MMP20 active-site mutation in hypomaturation amelogenesis imperfecta.

D Ozdemir1, P S Hart, O H Ryu, S J Choi, M Ozdemir-Karatas, E Firatli, N Piesco, T C Hart.   

Abstract

The Amelogenesis Imperfecta (AI) are a group of clinically and genetically heterogeneous disorders that affect enamel formation. To date, mutations in 4 genes have been reported in various types of AI. Mutations in the genes encoding the 2 enamel proteases, matrix metalloproteinase 20 (MMP20) and kallikrein 4 (KLK4), have each been reported in a single family segregating autosomal-recessive hypomaturation AI. To determine the frequency of mutations in these genes, we analyzed 15 Turkish probands with autosomal-recessive hypomaturation AI for MMP20 and KLK4 gene mutations. No KLK4 mutations were found. A novel MMP20 mutation (g.16250T>A) was found in one family. This missense mutation changed the conserved active-site His226 residue of the zinc catalytic domain to Gln (p.H226Q). Zymogram analysis demonstrated that this missense mutation abolished MMP20 proteolytic activity. No MMP20 mutations were found in the remaining 14 probands, underscoring the genetic heterogeneity of hypomaturation AI.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16246936      PMCID: PMC1850238          DOI: 10.1177/154405910508401112

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  23 in total

Review 1.  Matrix metalloproteinases.

Authors:  H Nagase; J F Woessner
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

2.  Mutation in kallikrein 4 causes autosomal recessive hypomaturation amelogenesis imperfecta.

Authors:  P S Hart; T C Hart; M D Michalec; O H Ryu; D Simmons; S Hong; J T Wright
Journal:  J Med Genet       Date:  2004-07       Impact factor: 6.318

Review 3.  Proteinases in developing dental enamel.

Authors:  J D Bartlett; J P Simmer
Journal:  Crit Rev Oral Biol Med       Date:  1999

4.  MMP-20 mutation in autosomal recessive pigmented hypomaturation amelogenesis imperfecta.

Authors:  J-W Kim; J P Simmer; T C Hart; P S Hart; M D Ramaswami; J D Bartlett; J C-C Hu
Journal:  J Med Genet       Date:  2005-03       Impact factor: 6.318

5.  ENAM mutations in autosomal-dominant amelogenesis imperfecta.

Authors:  J-W Kim; F Seymen; B P-J Lin; B Kiziltan; K Gencay; J P Simmer; J C-C Hu
Journal:  J Dent Res       Date:  2005-03       Impact factor: 6.116

6.  Characterization of recombinant pig enamelysin activity and cleavage of recombinant pig and mouse amelogenins.

Authors:  O H Ryu; A G Fincham; C C Hu; C Zhang; Q Qian; J D Bartlett; J P Simmer
Journal:  J Dent Res       Date:  1999-03       Impact factor: 6.116

7.  Identification and structural and functional characterization of human enamelysin (MMP-20).

Authors:  E Llano; A M Pendás; V Knäuper; T Sorsa; T Salo; E Salido; G Murphy; J P Simmer; J D Bartlett; C López-Otín
Journal:  Biochemistry       Date:  1997-12-09       Impact factor: 3.162

8.  Decreased mineral content in MMP-20 null mouse enamel is prominent during the maturation stage.

Authors:  J D Bartlett; E Beniash; D H Lee; C E Smith
Journal:  J Dent Res       Date:  2004-12       Impact factor: 6.116

9.  Amelogenin p.M1T and p.W4S mutations underlying hypoplastic X-linked amelogenesis imperfecta.

Authors:  J-W Kim; J P Simmer; Y Y Hu; B P-L Lin; C Boyd; J T Wright; C J M Yamada; S K Rayes; R J Feigal; J C-C Hu
Journal:  J Dent Res       Date:  2004-05       Impact factor: 6.116

Review 10.  Amelogenesis imperfecta, dentinogenesis imperfecta and dentin dysplasia revisited: problems in classification.

Authors:  C J Witkop
Journal:  J Oral Pathol       Date:  1988-11
View more
  54 in total

Review 1.  Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted.

Authors:  Kendra J Greenlee; Zena Werb; Farrah Kheradmand
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

2.  Identification of novel genes expressed during mouse tooth development by microarray gene expression analysis.

Authors:  Trevor J Pemberton; Fang-Yuan Li; Shoji Oka; Gustavo A Mendoza-Fandino; Ya-Hsuan Hsu; Pablo Bringas; Yang Chai; Malcolm L Snead; Ruty Mehrian-Shai; Pragna I Patel
Journal:  Dev Dyn       Date:  2007-08       Impact factor: 3.780

3.  Disorders of human dentin.

Authors:  P Suzanne Hart; Thomas C Hart
Journal:  Cells Tissues Organs       Date:  2007       Impact factor: 2.481

Review 4.  DENTAL ENAMEL FORMATION AND IMPLICATIONS FOR ORAL HEALTH AND DISEASE.

Authors:  Rodrigo S Lacruz; Stefan Habelitz; J Timothy Wright; Michael L Paine
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

5.  The proteolytic processing of amelogenin by enamel matrix metalloproteinase (MMP-20) is controlled by mineral ions.

Authors:  Feroz Khan; Haichuan Liu; Aileen Reyes; H Ewa Witkowska; Olga Martinez-Avila; Li Zhu; Wu Li; Stefan Habelitz
Journal:  Biochim Biophys Acta       Date:  2013-03

6.  The Presence of MMP-20 Reinforces Biomimetic Enamel Regrowth.

Authors:  S Prajapati; Q Ruan; K Mukherjee; S Nutt; J Moradian-Oldak
Journal:  J Dent Res       Date:  2017-08-28       Impact factor: 6.116

7.  Target gene analyses of 39 amelogenesis imperfecta kindreds.

Authors:  Hui-Chen Chan; Ninna M R P Estrella; Rachel N Milkovich; Jung-Wook Kim; James P Simmer; Jan C-C Hu
Journal:  Eur J Oral Sci       Date:  2011-12       Impact factor: 2.612

8.  MMP20 hemopexin domain mutation in amelogenesis imperfecta.

Authors:  S-K Lee; F Seymen; H-Y Kang; K-E Lee; K Gencay; B Tuna; J-W Kim
Journal:  J Dent Res       Date:  2010-01       Impact factor: 6.116

Review 9.  Common mechanisms in development and disease: BMP signaling in craniofacial development.

Authors:  Daniel Graf; Zeba Malik; Satoru Hayano; Yuji Mishina
Journal:  Cytokine Growth Factor Rev       Date:  2015-11-24       Impact factor: 7.638

Review 10.  Multilevel complex interactions between genetic, epigenetic and environmental factors in the aetiology of anomalies of dental development.

Authors:  A H Brook
Journal:  Arch Oral Biol       Date:  2009-11-13       Impact factor: 2.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.